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Abstract Proper protein folding is crucial for protein stability and function; when 
folding fails, due to stress or genetic mutations, proteins can become toxic. Cells 
have evolved a complex protein quality control (PQC) system to protect against the 
toxicity exerted by aberrantly folded proteins, because these species can accumulate 
in various cellular compartments perturbing essential cellular activities, ultimately 
leading to cell and neuron death. The PQC comprises molecular chaperones, 
 degradative systems (proteasome and autophagy) and components of the unfolded 
protein response. Prevention of protein aggregation, clearance of misfolded sub-
strates and attenuation of translation, which decreases the amount of misfolding 
clients to levels manageable by the molecular chaperones, are all key steps for the 
maintenance of proteostasis and cell survival. In parallel, alteration of proteostasis 
may also (indirectly) influence RNA homeostasis; in fact, RNA-containing 
 aggregates, known as stress granules, accumulate in cells with impaired PQC and 
autophagy and colocalize with proteinaceous aggregates in several neurodegenera-
tive diseases. Among the different molecular chaperones, here we will focus on the 
small heat shock protein HSPB8, which is expressed in neurons in basal conditions 
and upregulated in response to misfolded protein accumulation. HSPB8 exerts 
 protective functions in several models of protein conformation neurodegenerative 
diseases. The putative sites of action of HSPB8 that confer HSPB8 pro-survival and 
anti-aggregation functions are discussed, as well as its potential role at the cross-
road between proteostasis and ribostasis.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Keywords  Protein misfolding • Protein aggregation • Translation attenuation 
• HSPB8- BAG3 • Autophagy • Neurodegeneration • Polyglutamine diseases 
• Amyotrophic lateral sclerosis
Abbreviations
AD Alzheimer’s disease
ALS Amyotrophic lateral sclerosis
ATG Autophagy
ATX2 Ataxin 2
eIF2α Eukaryotic initiation factor 2 on Ser51 of the α subunit
FTLD-U Frontotemporal lobar degeneration with ubiquitin-positive inclusions
FUS Fused in sarcoma
HD Huntington’s disease
hnRNPA1 Heterogeneous nuclear ribonucleoprotein A1
HSP Heat shock protein
IBMPFD Inclusion body myopathy with early-onset Paget disease and fronto-
temporal dementia
JNK c-Jun N-terminal kinase
KD Kennedy’s disease
LAMP2A Lysosome-associated membrane protein 2A
LC3 Microtubule-associated protein 1A/1B-light chain 3
MKK7 Mitogen-activated Protein Kinase Kinase 7
MSP Multisystem proteinopathy
NBR1 Neighbor of BRCA1 gene 1
PD Parkinson’s disease
PERK Protein kinase RNA-like endoplasmic reticulum kinase
polyQ Polyglutamine
PQC Protein quality control
RACK1 Receptor for Activated C Kinase 1
rhoA Ras homolog gene family member A
RNPs Ribonucleic proteins
ROCK1 Rho-associated coiled-coil containing protein kinase 1
SCA3 Spinocerebellar ataxia 3
SG Stress granule
SOD1 Superoxide dismutase 1
SQSTM1 Sequestosome 1
TDP-43 TAR DNA-binding protein 43
TIA-1 T-cell intracytoplasmic antigen
TRAF2 TNF receptor-associated factor 2
UPS Ubiquitin proteasome system
VCP Valosin containing protein
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21.1  Protein Quality Control: Guardian of Cellular Health
21.1.1  The Physiological Activation of the Protein  
Quality Control System
Protein homeostasis refers to the ability of cells to maintain an appropriate balance 
among protein synthesis, folding, assembly, translocation and clearance (Morimoto 
and Cuervo 2014). Protein homeostasis is ensured and modulated by the protein 
quality control (PQC) system and is essential for the long-term viability and health 
of the cells. Malfunction and deregulation of the PQC system are severe risk factors 
for the development of protein conformation diseases characterized by the accumu-
lation of aggregated proteins (Bence et al. 2001; Douglas and Dillin 2010).
The PQC system includes molecular chaperones, degradative systems and stress- 
inducible pathways. Molecular chaperones (typically heat shock proteins, HSPs) 
are expressed in multiple cell compartments and survey protein quality by either 
assisting protein folding (both co- and post-translational folding) or directing aber-
rant proteins to degradation and thereby protecting against misfolding (Hartl 1996). 
Molecular chaperones also assist assembly and disassembly of macromolecular 
complexes, as well as protein translocation (Hartl and Hayer-Hartl 2002; Deuerling 
and Bukau 2004; Ron and Walter 2007). Unfolded substrates are repeatedly bound 
and held by molecular chaperones to avoid their irreversible aggregation (Hartl 
et al. 2011). There are several classes of molecular chaperones, which may also 
work with the assistance of co-chaperones and/or interactors of different nature; 
moreover, some chaperones are ATP-independent (e.g. small heat shock proteins, 
sHSPs/HSPBs) (Gobbo et al. 2011), while other are ATP-dependent (Hsc70/HSPA8 
and Hsp70/HSPA1A) (Hartl et al. 2011). Both ATP-independent and ATP-dependent 
chaperones can bind to the unfolded substrates. Instead, folding of the bound client 
to the native state is regulated by Hsp70 and ATP hydrolysis (Hartl et al. 2011). 
Nucleotide binding to Hsp70 and hydrolysis coupled to the release of the folded 
substrate is further regulated by co-chaperones including proteins of the Bag family 
(BAG1-BAG6), DNAJ/Hsp40 and Hip (Hartl et al. 2011), which also provide the 
specificity for interaction of chaperones with client proteins. When misfolding 
 cannot be prevented (e.g. due to protein damage, denaturation, oxidation or genetic 
mutation), proteins cannot mature into their fully active state, lose their function and 
become aggregation-prone, eventually acquiring toxic functions. Under these con-
ditions, as well as when refolding fails, molecular chaperones assist the degradation 
of the bound client acting in concert with two major degradative systems: the 
ubiquitin- proteasome system (UPS) and lysosome-based degradation. The latter 
includes macroautophagy (here referred to as autophagy) and chaperone-mediated 
autophagy (CMA) (Cuervo and Wong 2014; Parzych and Klionsky 2014).
The UPS is a low capacity, but highly specific and selective proteolytic system 
that degrades short-lived proteins labeled with ubiquitin moieties (Ciechanover 
2005; Ciechanover and Brundin 2003). The proteasome has a barrel shape, so that 
to be degraded by this system proteins must first be ubiquitinated and unfolded, in 
[AU1]
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order to acquire the capability to enter its narrow central cavity; globular or irrevers-
ibly aggregated proteins cannot be processed by the proteasome. Among the molec-
ular chaperones and co-chaperones that assist the proteasomal mediated degradation 
of ubiquitinated substrates are HSPAs/DNAJs and HSPA/BAG1 complexes (Alberti 
et al. 2002; Demand et al. 2001; Kampinga and Craig 2010).
Autophagy is a high capacity and non-specific multi-step process in which cyto-
solic material is sequestered in a double-membrane vesicle, the phagophore/
autophagosome; the latter then fuses with the lysosome delivering its inner content 
for degradation by enzymatic hydrolysis, greatly facilitated by the acidic environ-
ment of the resulting intracellular compartment (Parzych and Klionsky 2014). 
Although autophagy has been initially described as a bulk nonspecific degradation 
process that mainly clears long-lived proteins and organelles, recent evidence has 
highlighted that autophagy plays a crucial role in the selective elimination of 
unwanted components such as dysfunctional organelles, pathogens and also  aberrant 
protein aggregates (Klionsky and Emr 2000; Hara et al. 2006; Komatsu et al. 2006). 
In particular, it has emerged that autophagy can also selectively degrade ubiquiti-
nated proteins (Bjorkoy et al. 2005). The recognition of ubiquitinated substrates is 
done by autophagy adaptors including SQSTM1 (also known as p62), NBR1 and 
valosin containing protein (VCP), which bind both to ubiquitin and the autophago-
some-specific proteins members of the LC3/GABARAP/Gate16 family (Johansen 
and Lamark 2011). Specific chaperones and co-chaperones can participate in the 
delivery of bound clients to autophagosomes, including BAG3 (Carra et al. 2008a). 
Another example of the tight cooperation between chaperones and lysosome-based 
degradation is CMA, which removes a specific subset of proteins containing the 
pentapeptide lysosome-targeting motif (KFERQ). These substrates are directly 
translocated into the lysosome after docking to the LAMP2A and unfolding by a 
chaperone complex containing HSPA8 and the co-chaperones BAG1, HSPA8-
interacting protein (Hip), Hsp-organising protein (Hop) and HSP40/DNAJB1 
(Cuervo and Wong 2014).
21.1.2  Protein Damage and the PQC System
When cells are exposed to acute or chronic stress, protein homeostasis is challenged 
and the protein-folding equilibrium is altered. Cells respond by increasing the 
expression of genes that protect against proteotoxic stress, including HSPs and do 
so by instantaneously stimulating the heat-shock response (HSR) (Anckar and 
Sistonen 2011; Morimoto 2008), often mediated by specific sensors that activate 
transcription factors, such as the heat shock factor 1 (HSF-1), which controls  several 
genes of the HSR. Existing and newly synthesized molecular chaperones capture 
the folding intermediates to prevent misfolding and aggregation and to facilitate 
refolding or degradation, and the entire PCQ system machinery is potentiated under 
these conditions. In parallel, cells temporarily attenuate translation allowing a 
decrease in the total intracellular levels of misfolding proteins to amounts 
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manageable by the molecular chaperones (Tsaytler et al. 2011). Translation attenu-
ation is triggered by the accumulation of unfolded proteins within the endoplasmic 
 reticulum (ER) (Ron and Walter 2007). This, in fact, leads to PERK-mediated phos-
phorylation of eukaryotic initiation factor 2 on Ser51 of the α subunit (eIF2α), 
thereby resulting in the temporary sequestration of mRNAs encoding for “house-
keeping” functions in cytoplasmic foci called stress granules (SGs) and inhibiting 
their  translation (Kedersha and Anderson 2002). Sequestration of mRNAs encoding 
for “housekeeping” functions within SGs also prioritizes the synthesis of chaper-
ones and enzymes needed for the stress response, while protecting and storing 
mRNAs during stress (Kedersha and Anderson 2002). Potential cell damage asso-
ciated with the response to increased levels of misfolded proteins can be attenu-
ated by the sequestration into SGs of scaffold proteins (e.g. JNK, MKK7, rhoA) 
and pro- apoptotic proteins (e.g. RACK1, ROCK1, TRAF2), thus respectively modu-
lating signaling cascades and inhibiting apoptosis during stress, generating a well- 
integrated stress response system (Buchan and Parker 2009; Kedersha et al. 2000; 
Takahashi et al. 2012). Once the stress is relieved, SGs, which are highly dynamic, 
disassemble, restoring proper translation within cells. Persistent SGs will be removed 
by autophagy, with the assistance of the ubiquitin chaperone VCP (Buchan et al. 
2013), thereby also contributing to the recovery of protein homeostasis.
21.2  Protein Aggregation and Proteostasis Imbalance 
in Neurodegenerative Diseases
Misfolding and aggregation are common molecular events that affect several organs 
and tissues and are responsible for a large number of human diseases, including 
neurodegenerative and neuromuscular diseases. All the diseases that are character-
ized by the presence of proteinaceous aggregates have been called conformational 
diseases (Chiti and Dobson 2006). Conformational diseases affecting the brain 
include repeat expansion diseases, such as CAG-repeat/polyglutamine (polyQ) 
related diseases (e.g. Huntington’s disease (HD), spinal and bulbar muscular  atrophy 
(SBMA), and spinocerebellar ataxias (SCAs)), C9ORF72/GGGGCC related  diseases 
(e.g. most familial forms of amyotrophic lateral sclerosis (ALS), frontotemporal 
dementia (FTD), etc. as well as non-repeat expansion diseases including Parkinson’s 
disease (PD), amyotrophic lateral sclerosis (ALS), prion disease, and Alzheimer’s 
disease (AD), which may appear both in sporadic or familial forms. In the latter 
cases, the inheritance is associated to mutations of a specific gene whose product 
cannot fold properly. Little is known on the sporadic forms, but often alteration of 
components of the PCQ system is present, supporting a direct link between imbal-
ance in proteostasis and disease onset and/or progression-severity. Depending on 
the type of disease (and type of disease-related protein) aggregates/fibrils accumu-
late in different neuronal populations/brain areas, which correlate with different 
symptoms and are always associated with a progressive (fatal) clinical course 
(Cummings and Zoghbi 2000). However, it is important to underline that not all 
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aggregated species are toxic, as neuronal death does not always correlate with the 
presence of aggregates. Protein aggregation is a multi-step process in which pre- 
fibrillar detergent soluble species assemble into large fibrillar non-detergent soluble 
species (Chiti and Dobson 2006). The neurotoxicity of the different forms of these 
aggregates/inclusions is still largely debated and in general large macromolecular 
aggregates are nowadays believed to be protective, while intermediate species 
would exert high toxicity. Macroscopic aggregates (inclusion bodies) would exert a 
protective role by trapping the early neurotoxic species into a specific subcellular 
compartment, waiting for their clearance from the cells. Microaggregates/intermediate 
species can exert toxicity acting at different steps, such as sequestration of cellular 
components, particularly transcription factors which are essential for neuronal 
 survival (McCampbell et al. 2000; Kikis et al. 2010), alteration of the intracellular 
trafficking of molecules and organelles, possibly affecting axonal transport (Sau 
et al. 2011; Lee et al. 2004). Independent of the type of aggregate and/or of the 
precise step at which misfolded proteins exert their toxicity, the overall reduction or 
the prevention of protein misfolding and/or aggregation in neurons, as well as the 
enhanced clearance of the aggregating/aggregated species are considered to be 
potentially neuroprotective. Decreased aggregation of misfolded proteins and 
increased clearance can be achieved by potentiating the molecular chaperones, 
which act in concert with the degradation systems UPS and/or autophagy and by 
directly stimulating autophagy with pharmacologic agents. Indeed, the protective 
role of specific molecular chaperones and co-chaperones (e.g. members of the 
HSPA, DNAJ and HSPB families) has been well established using both cellular and 
animal models of protein conformational neurodegenerative disorders or by poten-
tiating autophagy-mediated clearance (Carra et al. 2008a; Crippa et al. 2010; 
Hageman et al. 2010; Ravikumar et al. 2004; Rubinsztein 2006; Vos et al. 2010).
21.3  Ribostasis, Stress Granules and Protein  
Conformation Diseases
Recent observations demonstrated that several neurodegenerative diseases are 
 characterized by the accumulation of nuclear or cytoplasmic RNA-protein (RNP) 
aggregates. These RNP aggregates often contain stress granule markers and can 
colocalize with proteinaceous fibrillar aggregates. Most notably, in sporadic and 
familial forms of ALS, frontotemporal lobar degeneration with ubiquitin-positive 
inclusions (FTLD-U), multisystem proteinopathy (MSP), but also HD and AD 
(Schwab et al. 2008; Wilson et al. 2011), TDP-43, which is a nuclear RNA-binding 
protein, redistributes from the nucleus to cytoplasm, where it colocalizes with 
 proteinaceous inclusions. These observations strongly suggest that a tight connec-
tion/cross-talk between protein and RNA homeostasis exists and that altered RNP/
SG assembly, as well as impaired SG clearance may contribute to protein conforma-
tion diseases. This is further suggested by the fact that mutations in TDP-43 and in 
A. Poletti and S. Carra
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
a number of other mRNA-binding proteins, including FUS, hnRNPA1, ATX2 are 
associated with neurodegenerative diseases, namely ALS, MSP, spinocerebellar 
ataxia type 2 (SCA2) or constitute a risk factor in other diseases (e.g. ATX2 is a risk 
factor for ALS (Laffita-Mesa et al. 2013)). Intriguingly, when mutated these mRNA-
binding proteins aberrantly assemble into SGs upon stress, pointing to altered SG 
dynamics (assembly and disassembly) as important pathomechanism (Acosta et al. 
2014). In fact, SGs play a crucial role in protecting and storing mRNAs during 
stress, as well as indirectly modulating signaling pathways (e.g. by sequestration of 
specific factors), altered SG dynamic may in turn affect RNA homeostasis. Thus, 
with this mechanism SG aggregates could alter the population of mRNAs available 
for translation, which may also contribute to disease.
What molecular events lead to persistence of SGs and colocalization of SG 
 components with proteinaceous inclusions in protein conformation diseases is still 
largely unknown. Curiously, many of the mRNA-binding proteins involved in SG 
assembly (or recruited to SGs) contain prion-like domains (e.g. TIA-1, TDP-43, 
hnRNPA1), which allow them to self-aggregate/polymerize, and trigger SG assembly 
(Gilks et al. 2004; Li et al. 2013). However, unlike prionogenic fibrillar aggregates, 
which are irreversible, during normal SGs metabolism, the prion-like domains 
present in the mRNA-binding proteins reversibly assemble and disassemble ensur-
ing their dynamic nature. The presence of deregulated expression or of mutations in 
RNA-binding proteins may confer the tendency to form stable amyloid structure 
mediated by the prion-like domains, which would cause a defective SG disassem-
bly. Accumulation of persistent altered SGs may not only alter RNA metabolism 
and homeostasis, but also favor protein aggregation; in fact, improperly disassem-
bled SGs or partly disassembled SGs may act as seed for aggregation, due to the 
presence of proteins with highly aggregation-prone prion-like domains. Alternatively, 
but not mutually exclusively, defects in clearance mechanisms, deregulated autoph-
agy and accumulation of other aggregate-prone proteins, as it occurs in protein 
 conformation diseases, could contribute to an increase in the frequency of amyloid 
initiation at SGs. This may change SG assembly dynamics and composition, favor-
ing SG accumulation and/or coalescence with aggregates/inclusion bodies (which 
would participate in disease progression). In both scenarios, cells rely on an efficient 
PQC system and autophagy flux to properly clear unassembled SGs, thereby 
 maintaining both RNA and protein homeostasis. In line with this hypothesis, muta-
tions of VCP are associated with ALS and MSP (Inclusion body myopathy with 
early-onset Paget disease and frontotemporal dementia/IBMPFD), characterized by 
the accumulation of ubiquitinated inclusions that colocalize with the SG marker 
TDP-43 (Ju et al. 2008; Ju and Weihl 2010). Intriguingly, VCP is a ubiquitin 
 chaperone involved in the autophagy-mediated clearance of SGs (Buchan et al. 
2013), as well as in the modulation of autophagosome formation and autophagy-
mediated ubiquitinated client degradation (Ju et al. 2009). This further points to a 
tight connection between altered proteostasis and RNA processing in disease and 
suggests that boosting molecular chaperones and degradative systems may be 
 beneficial in preventing RNA aggregation and dysfunction (besides decreasing 
 protein  aggregation and aggregate-mediated toxicity).
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21.4  eIF2α: Master Regulator of Protein Synthesis,  
SGs and Autophagy
As previously mentioned, upon stress cells activate a sophisticated integrated 
response aimed to conserve energy and divert cellular resources toward survival. 
This includes the temporary shut-down of translation (to decrease the load of 
unfolding chains for the existing molecular chaperones), upregulation of molecular 
chaperones (which are essential to avoid irreversible protein aggregation, as well as 
protein-RNA aberrant aggregation) and activation of autophagy (to clear the 
 misfolded accumulating proteins) (Ron and Walter 2007). Key to these events is 
the phosphorylation of eIF2α. In fact, upon stress phosphorylation of eIF2α on one 
hand induces the conversion of LC3-I into LC3-II, which corresponds to the 
 lipidated autophagosome-anchored form, and on the other hand induces the expres-
sion of key autophagy genes (e.g. ATG5) (Kouroku et al. 2007). Impairment in the 
activation of the eIF2α stress response renders the cells more vulnerable to the 
 toxicity mediated by aggregate-prone proteins such as polyQ proteins, leading to 
accumulation of proteinaceous aggregates and activation of apoptosis (Kouroku 
et al. 2007). In parallel, phosphorylation of eIF2α promotes SG assembly (although 
SG formation can occur also independently of eIF2α phosphorylation) (Anderson 
and Kedersha 2002; Mazroui et al. 2007). SG assembly is triggered after translation 
shut-down and polyribosome disassembly and is not required for translation 
attenuation (Anderson and Kedersha 2008). While the beneficial role of autophagy 
stimulation and translation attenuation upon stress has been well documented, it has 
not yet been elucidated whether the SG response induced by phospho-eIF2α 
contributes directly, as an early event, in protein homeostasis and to what extent 
cross-talk between SG response and PQC exists. Interestingly, the ubiquitin chaper-
one VCP participates in SG clearance and several players of the PQC system are 
components of SGs or even modulate their assembly (e.g. ubiquitin and HDAC6, 
respectively) (Buchan et al. 2013; Kwon et al. 2007). This strongly points to a 
close interplay between the sensors of proteotoxicity (unfolded protein response, 
UPR), specific molecular chaperones, eIF2α phosphorylation, SG response and 
autophagy- mediated clearance. Thus, alteration in the activation of the eIF2α path-
way or dysfunction of key players upstream or downstream of this pathway could 
also alter SG response (and indirectly RNA metabolism and/or stability upon stress), 
favor protein overload and protein misfolding/accumulation. In parallel, due to the 
inefficient activation of autophagy, persistent SGs would accumulate (Buchan et al. 
2013). In combination these observations suggest that modulation of target proteins 
that can induce phospho-eIF2α, thereby promoting or facilitating temporary transla-
tion shut-down, autophagy and, eventually also SG response, may be beneficial in 
restoring and/or maintaining cell health. Interestingly, specific molecular chaperones 
such as the small heat shock protein HSPB8 can modulate (indirectly) via phospho- 
eIF2α both events, thereby exerting a protective function under proteotoxic stress 
conditions (see later) (Carra et al. 2009). To what extent molecular chaperones 
 participate in the modulation of SG response and dynamic and whether/how this 
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correlates with their protective/pro-survival role is still largely unknown and is 
 certainly a field to be investigated in the future.
21.5  HSPBs: Implication in Neurodegenerative 
and Neuromuscular Diseases
Small heat shock proteins belong to the superfamily of ATP-independent chaper-
ones. The mammalian small heat shock protein family comprises ten members 
(HSPB1-10) (Fontaine et al. 2003; Kappe et al. 2003). From the functional point of 
view, two major functions have been attributed to HSPBs. First, some HSPB 
 proteins can stabilize the cytoskeleton (actin based microfilaments and intermediate 
filaments), especially under stress conditions (see chapter by J. Lavoie and J. Landry) 
(Lavoie et al. 1995). Second, HSPB proteins participate in the maintenance of 
 protein homeostasis by assisting the refolding (when possible) of misfolded 
aggregate- prone proteins, preventing their irreversible aggregation, and/or partici-
pating in their clearance (Carra et al. 2005; Vos et al. 2010). Due to their role in 
PQC, upregulation of some HSPBs has been implicated, indirectly or directly, in 
several neurodegenerative and neuromuscular disorders. Indeed, immunohisto-
chemical studies done on post-mortem human tissues from patients suffering from 
e.g. PD, AD, HD show upregulation of HSPB1, HSPB5, HSPB8 in the areas char-
acterized by neuronal damage/death and by reactive gliosis (Carra 2006; Seidel 
et al. 2011). Reactive gliosis is a reaction of the astrocytes to brain injury, resulting 
in morphological and functional changes of astrocytes and aimed at protecting the 
surrounding neuronal population from toxic insults and maintaining neuronal 
homeostasis. Interestingly, the highest expression levels of HSPB proteins are often 
observed in reactive astrocytes, which provide essential activities that preserve neu-
ronal function. The pathological significance of HSPBs up-regulation in areas char-
acterized by reactive gliosis and neurodegeneration is still largely not understood 
(Carra 2006); it is however assumed that it could be part of the stress response to 
neuronal damage to prevent/decrease the toxicity mediated by the aggregated 
mutated proteins (e.g. mutated polyQ proteins, mutated SOD1) (Carra et al. 2005; 
Crippa et al. 2010). This is further suggested by the findings that the transient over-
expression of several HSPBs, in vitro, in mammalian cells and in Drosophila mela-
nogaster models of protein conformation diseases, attenuates the aggregation of 
mutated proteins and protects against their mediated cytotoxicity (see also later: 
HSPB8, autophagy and protein degradation) (Carra et al. 2010; Vos et al. 2010; 
Gregory et al. 2012). Furthermore, transgenic flies overexpressing members of the 
Drosophila melanogaster (Dm) small heat shock protein family are protected against 
mutated polyglutamine-induced neurodegeneration, as well as aging-related decline 
in locomotor behavior (extension of life span and protection against oxidative stress 
have been found in Dm-Hsp22 transgenic flies) (Morrow et al. 2004a, b). In combi-
nation these data suggest that several members of the HSPB family display  protective 
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functions and are important player for maintaining neuronal and muscular cell 
 viability. This is further supported by the fact that mutations of several HSPB 
proteins (HSPB1, HSPB3, HSPB4, HSPB5, HSPB8) are associated with muscular 
and neurological disorders, including hereditary sensory and/or motor neuropathy 
(e.g. HSPB1, HSPB3, HSPB8), myofibrillar myopathy (HSPB5) and congenital 
cataract (HSPB4) (Boncoraglio et al. 2012; Irobi et al. 2004; Evgrafov et al. 2004; 
Kolb et al. 2010; Litt et al. 1998; Vicart et al. 1998).
In this chapter we will focus on the potentially protective function exerted by 
HSPB8 in neurodegenerative and neuromuscular diseases and we will highlight 
how HSPB8 may act at the crossroad of both protein synthesis and protein degradation, 
thereby participating in the maintenance of proteostasis.
21.6  HSPB8: At the Crossroad Between Protein Synthesis 
and Protein Aggregation
Differently from other members of the HSPB family that mainly exist as homo and/
or hetero-oligomers containing other HSPB partners (e.g. HSPB1, HSPB5), in cells, 
HSPB8 forms a stable and stoichiometric complex with the HSPA8 co-chaperone 
Bcl-2 associated athanogene BAG3 that contains a well-defined 2:1 HSPB8:BAG3 
ratio (Carra et al. 2008a). The different behavior of HSPB8, as compared to other 
“classical” HSPBs, was recently confirmed in vitro, using fluorescently labeled 
HSPBs and monitoring the type of hetero-oligomeric complexes formed. In particular, 
while HSPB1, HSPB5 and HSPB6 formed heterogeneous high molecular weight 
complexes and exchanged subunits, HSPB8 did not form stable complexes with 
either HSPB1 or HSPB5 (Datskevich et al. 2012). In mammalian cells, stability of 
HSPB8 is enhanced by its association with BAG3 (Carra et al. 2008a); this was 
confirmed in vitro studies, that also demonstrated that this interaction of HSPB8 and 
BAG3 leads both to an increase of thermal stability and an increased resistance to 
limited chymotrypsinolysis of HSPB8 (Shemetov and Gusev 2011). This makes 
HSPB8 an “atypical” member of the HSPB family, at least from the structural point 
of view. Although interaction of other members of the HSPB family with BAG3 has 
been reported (e.g. HSPB5 and HSPB6, but not HSPB1, can interact with BAG3) 
(Fuchs et al. 2010; Hishiya et al. 2010), the strength of these interactions was weaker 
as compared to HSPB8 affinity for BAG3 (Shemetov and Gusev 2011).
21.6.1  HSPB8, Autophagy and Protein Degradation
Concerning the functions of HSPB8, results from our laboratories, using cellular 
and Drosophila disease models of polyglutamine diseases, show that HSPB8, 
together with BAG3, reduced the aggregation of mutated polyglutamine proteins 
such as huntingtin, androgen receptor (AR) and ataxin 3, which are associated with 
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HD, KD and SCA3 (Carra et al. 2005, 2008a, 2010). Similarly, the HSPB8-BAG3 
complex inhibited the formation of insoluble species generated by misfolded 
mutated SOD1 and by a truncated form of TDP-43, associated/involved in familial 
or sporadic ALS (Crippa et al. 2010). Both the levels of high molecular weight 
oligomeric species and the insoluble aggregated species generated by mutated 
SOD1 and truncated TDP-43 were decreased by HSPB8 overexpression, suggesting 
that HSPB8 exerts its function on these misfolded proteins independently on their 
oligomeric state (Crippa et al. 2010). The reduced aggregation of misfolded  proteins 
in cells overexpressing HSPB8 is due to the facilitation of the autophagic process 
(Carra et al. 2008a). In fact, in autophagy deficient cells (ATG5−/−) or upon inhibi-
tion of autophagy with 3-methyladenine and wortmannin, HSPB8 and BAG3 were 
no longer able to inhibit the aggregation/accumulation of mutated polyQ proteins, 
SOD1 and TDP-43 (Carra et al. 2005; Crippa et al. 2010). From the mechanistic 
point of view, such anti-aggregation and pro-degradative function of HSPB8 
depends on its association with the partner BAG3, as knockdown of the latter dimin-
ishes HSPB8 ability to inhibit mutated protein aggregation (Carra et al. 2008b). 
Moreover, the work of several independent laboratories demonstrated that the 
HSPB8-BAG3-HSPA8 complex not only facilitates autophagy flux, but is involved 
also in client binding and targeting to autophagosomes for degradation (Arndt et al. 
2010; Carra et al. 2008a; Gamerdinger et al. 2011). In particular, BAG3 possesses a 
dynein binding domain, which allows binding of the HSPB8-BAG3 complex to 
dynein and transport of the bound cargo to the microtubule organization center 
(MTOC) (Gamerdinger et al. 2011). Here, at the MTOC, autophagosomes are 
mainly assembled and highly concentrated, favouring cargo engulfing and degrada-
tion within autophagosomes. If not efficiently degraded, the bound cargo is targeted 
to the aggresome. Indeed, the aggresome is a dynamic structure that forms, at the 
MTOC, in response to an overload of improperly folded proteins (Kopito 2000). 
Thus, when autophagy flux is insufficient or dysregulated, as it occurs in neurode-
generative diseases, the dynein-mediated retrograde transport may not be fully 
paralleled by the rate of autophagosome formation; this would lead to the typical 
accumulation of aggresomes found in protein conformation diseases.
Concerning the stimulation of autophagy, overexpression of HSPB8 and/or 
BAG3 in mammalian cells (HeLa, HEK293T) induces the LC3-II (autophagosome- 
anchored)/LC3-I ratio, which corresponds to an increased formation of autophagosomes 
(Carra et al. 2008b, 2009). The complex also increases the fusion of autophago-
somes with lysosomes, as measured using specific inhibitors of the fusion step, 
thereby favoring autophagy-mediated degradation of different substrates (Carra 
et al. 2008b). In contrast, knocking down the HSPB8-BAG3 complex leads to a 
decreased activation of autophagy in basal conditions particularly under proteotoxic 
stress, thus rendering the cells more vulnerable to proteotoxicity (Carra et al. 2008b; 
Rapino et al. 2013); this is accompanied by a large increase in the accumulation of 
insoluble proteins within the cells. The activation of autophagy by HSPB8- BAG3 
observed in the cell lines tested (e.g. HEK293T, HeLa) is a consequence of the 
induction of the phosphorylation of eIF2α. In fact, on one hand co-transfection of 
HSPB8 (and BAG3) with GADD34, which promotes the dephosphorylation of 
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eIF2α, abrogates HSPB8 (and BAG3) mediated induction of autophagy (Carra et al. 
2009). On the other hand, overexpression of HSPB8 (and BAG3) induces the 
phosphorylation of eIF2α, both in cells and in vitro. Such induction of phospho-
eIF2α upon HSPB8-BAG3 overexpression is generally observed prior to obvious 
effects on the LC3-II/LC3-I ratio. In particular, while we observed induced 
phospho-eIF2α typically between 16 and 24 h after transfection of the chaperone 
complex, the maximal effects on autophagy were observed between 24 and 48 h 
post-transfection in cells overexpressing HSPB8-BAG3 ((Carra et al. 2009) and 
Carra, unpublished). As mentioned above phospho-eIF2α induces the expression of 
key autophagy genes, including ATG5, thus explaining the delay between these two 
HSPB8-BAG3- mediated effects.
Concerning client binding and targeting, the HSPB8-BAG3-HSPA8 complex 
interacts with the E3 ligase CHIP (Arndt et al. 2010; Crippa et al. 2010) and with the 
autophagy receptor protein p62/SQSTM1 (sequestosome1) (Gamerdinger et al. 
2009). CHIP would ubiquitinate the HSPA8-bound substrates, while SQSTM1 is a 
multi-adaptor protein that simultaneously binds to ubiquitin and the autophagosome- 
associated protein LC3 (Bjorkoy et al. 2005; Pankiv et al. 2007), thereby linking 
polyubiquitinated proteins to the autophagic machinery. Actually, recent findings 
from our group show that BAG3 interacts, via HSPA8, with (poly)ubiquitinated pro-
teins; whether all these clients are ubiquitinated via CHIP is however still unknown 
(Minoia et al. Autophagy 2014, in press). Once bound by the HSPB8-BAG3- HSPA8 
complex, these clients are sequestered into cytoplasmic puncta that are labeled with 
the autophagic adapter/linker proteins SQSTM1, but also WIPI-1 and LC3. The 
sequestration of the ubiquitinated clients into SQSTM1-positive cytoplasmic puncta 
would avoid their proteasome-mediated degradation, thereby favoring their re-rout-
ing towards autophagy (Minoia et al., Autophagy 2014, in press). It is of note that 
while HSPB8 can colocalize with BAG3 and HSPA8 in these ubiquitin- SQSTM1-
containing cytoplasmic puncta, it is not strictly required for BAG3 binding to ubiq-
uitinated proteins as well as for BAG3-induced sequestration into cytoplasmic 
puncta, which depends entirely on BAG3 interaction with HSPA8. However, we 
observed that HSPB8 can also pull-down ubiquitinated proteins (Carra, unpub-
lished), similarly to HSPA8; this opens the possibility that HSPB8 may exert an 
additive role to the one of HSPA8 and participate in the targeting of specific clients 
to degradation. Alternatively, since we found that HSPB8 colocalizes with BAG3 in 
ubiquitin-positive cytoplasmic puncta especially after prolonged inhibition of the 
proteasome, our data suggest that HSPB8 may cooperate with HSPA8 and BAG3 in 
client re-routing especially under severe stress conditions (Carra, unpublished).
21.6.2  HSPB8 and Protein Synthesis
As previously mentioned, we found that overexpression of HSPB8 in mammalian 
cells leads to phosphorylation of eIF2α (Carra et al. 2009), which acts as a dominant 
inhibitor of the guanine nucleotide exchange factor eIF2B and prevents the recycling 
[AU2]
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of eIF2 between successive rounds of protein synthesis. As a consequence, translation 
is attenuated. A number of conditions result in eIF2α phosphorylation including 
heat shock, viral infection, nutrient deprivation, iron deficiency, and accumulation 
of unfolded or denatured proteins (Kimball 1999). In the case of cells overexpress-
ing HSPB8, increased levels of phospho-eIF2α is accompanied by the induction of 
key transcription factors (e.g. ATF4) and of autophagy (Carra et al. 2009). Both 
attenuation of translation and induction of autophagy participate in decreasing the 
accumulation and, subsequently, the aggregation of mutated misfolded proteins 
mediated by HSPB8 (Carra et al. 2009). The ability of HSPB8 to inhibit protein 
synthesis has been further demonstrated in vitro, using recombinant HSPB8 and 
cDNAs encoding for different substrates, thereby allowing a generalization of its 
effect (Carra et al. 2009). From the mechanistic point of view, it is still largely 
unknown how HSPB8 can trigger the phosphorylation of eIF2α. HSPB8 shows 
sequence similarity to the protein kinase coding domain of the large subunit of her-
pes simplex virus type 2 ribonucleotide reductase (ICP10) and displays a Mn2+-
dependent protein kinase activity (Smith et al. 2000). This autokinase activity of 
HSPB8 depends on the lysine 113 and permits it to phosphorylate specific substrates 
such as e.g. myelin basic protein (Chowdary et al. 2004; Depre et al. 2002). Its putative 
autokinase, both wildtype HSPB8 and the kinase-dead K113G mutant forms of 
HSPB8 could induce the phosphorylation of eIF2α, thereby excluding any direct 
role of HSPB8 as kinase at the level of eIF2α (Carra et al. 2009).
In parallel to the eIF2α signaling pathway, the phosphoinositide-3 kinase (PI3K) 
transduction pathway is also activated in response to a wide range of stresses (Bang 
et al. 2000). Recently it has been reported that a cross-talk between these pathways 
exists and that the eIF2α kinase PKR, which leads to phosphorylation of eIF2α, also 
acts upstream of PI3K and turns on the Akt/PKB-FRAP/mTOR pathway. From the 
mechanistic point of view, the activation of the PI3K pathway is indirect and requires 
the inhibition of protein synthesis by phospho-eIF2α. As a result, the apoptotic and 
protein synthesis inhibitory effects exerted by phospho-eIF2α are counterbalanced/
antagonized by the Akt/PKB-FRAP/mTOR pathway, which promotes cell prolifer-
ation and survival. Curiously, HSPB8 increases the phosphorylation of Akt and acts 
as survival and differentiation factor in hippocampal neurons (Ramirez-Rodriguez 
et al. 2013). Whether the induction of eIF2α phosphorylation is upstream of and 
required for the activation of Akt mediated by HSPB8 is currently unknown. 
Understanding how upregulation of HSPB8 leads to phosphorylation of eIF2α and 
whether this is linked to its role in cell survival (Akt activation) will unravel new 
targets whose modulation helps maintain proteostasis and boosts cell survival in 
stress and disease.
An inhibitory role in protein synthesis has been suggested also for another 
 member of the HSPB family, HSPB1 (Cuesta et al. 2000). However, this seems 
mechanistically unrelated to phosphorylation of eIF2α. During heat shock, HSPB1 
binds to the eukaryotic initiation factor eIF4G, promotes eIF4G insolubilization and 
prevents translation (Cuesta et al. 2000). Following heat shock, HSPB1 accumu-
lates together with eIF4G in heat shock granules; similarly to HSPB1, we observed 
accumulation of HSPB8 in heat-shock granules (Carra, unpublished). What is the 
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functional role of HSPB8 at the level of heat-shock granules and whether, similarly 
to HSPB1, HSPB8 can interact with eIF4G is not known.
21.6.3  HSPB8, eIF2α Phosphorylation and Stress Granules
As previously mentioned, upon stress, phosphorylation of eIF2α promotes SG 
assembly; however, it is of note that SGs can also be triggered in an eIF2α- 
independent manner, e.g. following inhibition of the proteasome or robust heat 
shock (Grousl et al. 2009; Mazroui et al. 2007). Formation of SGs is part of the 
integrated stress response aimed at cell survival and alteration in the dynamics of 
SGs has been associated with a number of pathological conditions. In particular, in 
protein conformation diseases such as CAG/polyQ diseases or in ALS, colocaliza-
tion of SG components with proteinaceous inclusions has been shown (Wolozin 
2014; Ramaswami et al. 2013). This may result from the presence of mutated 
 proteins that by itself can trigger SGs with altered dynamics (e.g. persistent SGs can 
be triggered by ALS-associated mutated FUS/TLS) as well as by the aberrant 
 clearance of SGs, which, in turn, can derive from impairment of the PQC system 
(inhibition of autophagy and VCP) (Ramaswami et al. 2013; Buchan et al. 2013); 
the two processes are not mutually exclusive, and may coexist. Whether HSPB8 
also influences the SG response, due to its action on phospho-eIF2α and whether, 
with its pro-autophagic activity, it participates in the clearance of persistent SGs, is 
currently unknown. However, considering that SG assembly is triggered by the self- 
aggregation of proteins that contain prion-like domains, it is plausible that specific 
chaperones are recruited into SGs to avoid irreversible aggregation of their compo-
nents, thereby maintaining their dynamic nature. We found that HSPB8 is recruited 
into SGs following several stress conditions, including heat shock, treatment with 
arsenite and inhibitors of the proteasome (Fig. 21.1a and Carra, unpublished). 
HSPB8 also colocalizes with mutated ALS-associated FUS R518K in SGs (Fig. 21.1b). 
Combined, these observations open the possibility that HSPB8 may participate in 
the PQC at the level of SGs. HSPB8 may contribute to avoid irreversible protein 
aggregation within SGs. When irreversible aggregation occurs and/or in the presence 
of mutated or damaged components of SGs, HSPB8 may cooperate with its partner 
BAG3 to target such components (or damaged and persistent SGs) to autophagy 
for degradation (Fig. 21.2). Indeed, SGs can be degraded by autophagy with the 
assistance of the ubiquitin chaperone VCP (Buchan et al. 2013).
Alternatively, but not mutually exclusive, HSPB8 may be recruited into SGs to 
serve specific functions, such as to regulate the activity of specific mRNA-binding 
proteins; for example HSPB8 interacts with two RNA-binding proteins: DEAD box 
protein Ddx20 (gemin3, DP103) and Src associated in mitosis of 68 kDa (Sam68) 
(Sun et al. 2010; Badri et al. 2006). The DEAD box proteins form a subgroup of the 
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DExD/H box family of helicases and have an ATP-dependent RNA unwinding 
(helicase) activity (Rocak and Linder 2004), and are involved in pre-mRNA 
processing, RNA turnover, RNA transcription, RNA export. In particular, Ddx20 
associates with a protein, the survival of motor neuron (SMN) protein, that when 
mutated is responsible for spinal muscular atrophy (SMA). Also SMN localizes to 
SGs and its overexpression induces SGs (Charroux et al. 1999; Hua and Zhou 
2004). SMN complexes are also involved in assembly and processing of diverse 
ribonucleoparticles (RNPs), including snRNPs (spliceosomes), snoRNPs, hnRNPs, 
transcriptosomes, and miRNPs (Pellizzoni et al. 2002). Sam68, associates with T-cell 
intracellular antigen-1 (TIA-1), a core component of SGs and localizes to SGs 
following oxidative stress (Henao-Mejia and He 2009; Henao-Mejia et al. 2009). At 
present, the functional significance of HSPB8 interaction with both Ddx20 and 
Sam68 is still largely unknown and may reflect a yet unraveled role of HSPB8 in 
modulating the function of these specific RNA-binding proteins, rather than their 
recruitment to SGs.
Fig. 21.1 HSPB8 is recruited into stress granules. (a) HeLa cells were heated at 43.5 °C for 
45 min, fixed in 4 % formaldehyde for 10 min at room temperature, followed by permeabilization 
with cold acetone for 5 min. Cells were processed for immunofluorescence with anti-HSPB8, anti-
TIA- 1, anti-G3BP and DAPI. TIA-1 and G3BP were used as markers of stress granules. (b) HeLa 
cells were transfected by calcium phosphate with a cDNA encoding for HA-tagged R518K-FUS 
(kindly provided by Dr. U. Pandey). Twenty four hours post-transfection cells were fixed as 
described in A and processed for immunofluorescence with anti-HSPB8, anti-HA and DAPI. (a, b) 
A 2.5× magnification of the selected area is shown
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Fig. 21.2 Schematic model of the known and putative sites of action of HSPB8. (1) Upon proteo-
toxic stress conditions, due to either external insult, ageing or genetic mutations, the amount of 
aberrantly folded substrates exceeds the capacity of the cells to properly assist their folding or 
clearance; as a result aggregation-prone proteins accumulate, leading to the activation of the 
protein quality control system. (2) Phosphorylation of eIF2α represents an early event and has 
several consequences: it allows to temporarily attenuate translation; it induces the assembly of SGs 
(3) and it induces the expression of specific genes, including essential autophagy genes (ATG5). 
SG assembly is triggered by the self-aggregation of RNA-binding proteins that contains a prion-
like domain, such as TIA-1, which translocates from the nucleus to the cytoplasm upon stress. 
Translocation into the cytoplasm and redistribution into SGs can also occur as a consequence of 
disease-associated mutations; in fact, TDP-43 and mutated FUS “aberrantly” redistribute into SGs. 
The molecular chaperone HSPB8 is also recruited at SGs but its function at this level is still largely 
unknown (4). (5) HSPB8, together with BAG3, is amongst the genes upregulated following 
proteotoxic stress (e.g. inhibition of the proteasome). HSPB8 and BAG3 participate in the stimula-
tion of the autophagic flux and assist the targeting of damaged clients to autophagy (6), thereby 
allowing to restore proteostasis. HSPB8, which is recruited into SGs and where it colocalizes 
with mutated FUS, may also participate in the maintenance of SG dynamics. HSPB8 may prevent 
aberrant protein aggregation at SGs or may target altered and persistent SGs or components thereof 
to autophagy for clearance (7)
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21.6.4  Mutated HSPB8 Is Associated with Motor  
Neuron Diseases
At present, three mutations (K141E, K141N and K141T) of HSPB8 have been 
associated with hereditary motor neuropathy (HMN) or with Charcot-Marie-Tooth 
type 2L (CMT-2L) disease and specifically target motor neurons (Irobi et al. 2004; 
Nakhro et al. 2013). The specific vulnerability of motor neurons to mutated HSPB8 
has been confirmed by overexpression studies in primary neuronal motor neuron 
cultures, where K141E and K141N HSPB8 caused neurite degeneration (the K141T 
mutation has been discovered recently and little experimental information is avail-
able concerning its properties) (Irobi et al. 2010). Instead, no significant toxicity 
was observed in primary sensory neurons, cortical neurons or glial cells overex-
pressing mutated HSPB8 (Irobi et al. 2010). Although it is still unclear why motor 
neurons are particularly sensitive to mutated HSPB8, recent data obtained by our 
group suggest that K141E and K141N are mainly characterized by loss of function 
(LOF) rather than by a toxic gain of function (GOF). In fact, the anti-aggregation 
and pro-degradative activities exerted by wildtype HSPB8 on misfolded mutated 
proteins such as mutated AR, huntingtin, ataxin-3, SOD1, TDP-43 and the mutated 
form P182L of HSPB1, which is also associated with HMN, were significantly 
decreased by its mutations (Carra et al. 2005, 2010). The observation that mutated 
HSPB8 is characterized by a loss of function in PQC was further confirmed in vivo, 
using a Drosophila model of the CAG/polyQ disease SCA3 (Carra et al. 2010). The 
reduced ability of mutated HSPB8 to block the accumulation of aggregate-prone 
substrates may be due to a (partial) loss of HSPB8 function at the level of protein 
synthesis regulation (phosphorylation of eIF2α), autophagy induction and/or targeting 
of clients to autolysosomes for degradation. The latter is supported by experimental 
finding showing that overexpression of mutated HSPB8 caused the accumulation of 
autophagosomes that colocalise with protein aggregates but fail to fuse with the 
lysosomes (Kwok et al. 2011). Instead, overexpression of wildtype HSPB8 increased 
the autophagic flux and colocalisation of autophagosomes with lysosomes (Kwok 
et al. 2011). Binding affinity of mutated HSPB8 to BAG3 was found to be decreased 
both in cells and in test-tube, using recombinant proteins (Carra et al. 2010; Shemetov 
and Gusev 2011). In parallel, our recent data demonstrate that within the HSPB8-
BAG3-HSPA8 complex, BAG3 seems to play a crucial role in client binding and 
re-routing towards autophagy as well as in stimulation of autophagic flux, while 
HSPB8 seems to act as helper (Minoia et al., Autophagy 2014 in press). In light of 
these observations, it is possible that the decreased ability of mutated HSPB8 to 
clear misfolded proteins and induce autophagic flux is a consequence of its reduced 
interaction/cooperation with BAG3 and of HSPB8’s own decreased stability 
(mutated HSPB8 by itself tends to aggregate) (Irobi et al. 2004). This would con-
tribute to motor neuropathy. In fact, defective autophagosome maturation and 
autophagic vacuole accumulation have been shown in a number of protein confor-
mational diseases as well as in HMNs/CMT disease. Moreover, genes directly 
involved in the endolysosomal and lysosomal pathway are mutated in HMNs (e.g. 
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mutations in Rab7, in lipopolysaccharide-induced tumor necrosis factor- alpha fac-
tor/small integral membrane protein of lysosome/late endosome, LITAF/SIMPLE) 
(Verhoeven et al. 2003; Street et al. 2003; Saifi et al. 2005), further supporting that 
deregulated autophagy contributes to motor neuron diseases and knockout of key 
autophagy genes causes neurodegeneration with accumulation of ubiquitin-positive 
inclusions (Komatsu et al. 2006). Whether a decreased autophagy induction also 
occurs in cells expressing mutated HSPB8 as a consequence of impaired modula-
tion of phospho-eIF2α and whether such mutant forms of HSPB8 may also  indirectly 
affect SG response/dynamics under stress is still unknown. However, it is of note 
that interplay between autophagy and SG clearance exists (Buchan et al. 2013) and 
that both deregulated autophagy and accumulation of SG components are hallmarks 
of motor neuron diseases, including ALS, IBMPFD (Wolozin 2014; Ramaswami 
et al. 2013). Thus, altered clearance of SGs as a consequence of decreased autopha-
gic flux may also occur and contribute to HSPB8- associated motor neuropathy. 
Future studies are needed to understand the exact mechanisms responsible for motor 
neuronal death in HSPB8-associated motor neuropathy and to explain what makes 
specifically motor neurons vulnerable to mutated HSPB8.
21.7  Conclusions and Perspectives
Accumulation of aggregated proteins is a hallmark of many neurodegenerative and 
muscular diseases, confirming that imbalance of protein homeostasis is deleterious 
for cell survival. To survive proteotoxic stress, due to external insults or genetic 
mutations, cells have evolved a well-orchestrated system, the protein quality (PQC) 
system. The PQC system avoids or limits irreversible protein aggregation, thereby 
maintaining normal protein homeostasis under many different intracellular or 
extracellular insults that affect protein stability and function. Key players of the 
PQC system are molecular chaperones, including both the heat shock proteins 
(HSPs) and the degradative pathways, mainly the proteasome and autophagy 
 systems. Upregulation of chaperones that can boost protein degradation, is normally 
beneficial in protein conformation models, but the protective functions exerted by 
specific molecular chaperones may be linked to their action not only at the level of 
proteins, but also in ribonucleoprotein complexes. In fact, in several neurodegenerative 
diseases, RNA-containing SGs colocalize with proteinaceous aggregates; thus, 
imbalance of ribonucleoprotein homoestasis may, concomitantly with proteostasis 
imbalance, contribute to disease and cell death. Intriguingly, the formation of these 
SGs is triggered, upon proteotoxic stress, by the self-reversible aggregation of 
RNA-binding proteins that contain prion-like domains; this suggests that chaper-
ones may also assist SG dynamics, avoiding irreversible RNA/protein aggregation 
at SGs (and SG persistence, which can be observed in neurodegenerative diseases). 
Alternatively, but not mutually exclusive, chaperones can recognize aberrant/dam-
aged SGs and target them (or components thereof, such as mutated FUS, TDP-43) 
to autophagy for degradation. How and to what extent molecular chaperones act at 
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the level of misfolded proteins, ribonucleoproteins and SGs, as well as on translation 
attenuation (which precedes SG formation) has attracted the attention of research-
ers. HSPB8 is an example of a chaperone that may act at different sites to help 
maintain both protein and RNA homeostasis. In fact, HSPB8 promotes the autoph-
agy-mediated clearance of aggregated proteins, induces the phosphorylation of 
eIF2α, which in turns triggers SGs and is itself recruited within SGs. Future research 
should investigate in more detail the link between protein and RNA homeostasis as 
well as the specific sites of action of chaperones, including HPB8. This will help 
unravel to what extent HSPB8 protective functions in protein conformation diseases 
are linked to its role in translation control, whether it assists SG dynamics or targets 
SG components to autophagy, which would also contribute to cell protection, or 
rather whether HSPB8 modulation of eIF2α phosphorylation and recruitment at 
SGs represent different, unrelated, activities. Therefore, a detailed characterization 
of the different partners and/or interactors recruited by HSPB8 to trigger one or all 
pathways acting synergistically to maintain protein and RNA balance, as well as the 
identification of small molecules capable of inducing HSPB8 expression in a cell-
specific manner will be fundamental to finding innovative approaches to counteract 
human diseases associated with proteotoxicity.
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